| Riverwoods Behavioral Health System | |
| 223 Medical Center Drive, Riverdale, Georgia 30274 | |
| (770) 991-8500 | |
| Not Available |
| Name | Riverwoods Behavioral Health System |
|---|---|
| Type | Psychiatric Hospital |
| Location | 223 Medical Center Drive, Riverdale, Georgia |
| Ownership | Proprietary |
| Emergency Services | No |
| Medicare ID (CCN) | 114035 |
| NPI Number | 1770742132 |
| Organization Name | RIVERWOODS BEHAVIORAL HEALTH, LLC |
| Doing Business As | RIVERWOODS BEHAVIORAL HEALTH SYSTEM |
| Address | 223 Medical Center Drive, Riverdale, GA 30274 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 770-991-8500 |
News Archive
Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has signed a strategic cooperation agreement with Timesco of London Ltd., one of the most progressive surgical and medical companies in the U.K.
Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced the addition of the TUNE detection cartridge to the SpectraMax Paradigm Multi-Mode Microplate Detection Platform. The breakthrough technology of TUNE with wavelength flexibility in a monochromator device and up to 10x the sensitivity will benefit both the research and screening markets.
For breast cancer screening, there are more clinical practice guidelines available to physicians than for any other medical procedure. A new study in the Journal for Healthcare Quality reports that when different clinical guidelines exist, physicians choose recommendations from multiple, sometimes conflicting, sources.
Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.
The Trust for America's Health (TFAH) applauds the President's budget for an overall increase in disease prevention funding, reflecting the new funds provided by the Prevention Fund from the Affordable Care Act (ACA), but expresses extreme concerns over the cuts to funding for core programs at the U.S. Centers for Disease Control and Prevention (CDC) and for emergency preparedness.
› Verified 2 days ago
News Archive
Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has signed a strategic cooperation agreement with Timesco of London Ltd., one of the most progressive surgical and medical companies in the U.K.
Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced the addition of the TUNE detection cartridge to the SpectraMax Paradigm Multi-Mode Microplate Detection Platform. The breakthrough technology of TUNE with wavelength flexibility in a monochromator device and up to 10x the sensitivity will benefit both the research and screening markets.
For breast cancer screening, there are more clinical practice guidelines available to physicians than for any other medical procedure. A new study in the Journal for Healthcare Quality reports that when different clinical guidelines exist, physicians choose recommendations from multiple, sometimes conflicting, sources.
Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.
The Trust for America's Health (TFAH) applauds the President's budget for an overall increase in disease prevention funding, reflecting the new funds provided by the Prevention Fund from the Affordable Care Act (ACA), but expresses extreme concerns over the cuts to funding for core programs at the U.S. Centers for Disease Control and Prevention (CDC) and for emergency preparedness.
› Verified 2 days ago
Southern Regional Medical Center Acute Care Hospital Location: 11 Upper Riverdale Road, Sw, Riverdale, Georgia 30274 Phone: (770) 991-8160 | |
Riverwoods Behavioral Health System Psychiatric Hospital Location: 223 Medical Center Drive, Riverdale, Georgia 30274 Phone: (770) 991-8500 |